1990 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesco Ernesto Pontieri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Parkinson Disease Medicine & Life Sciences
Dopamine Medicine & Life Sciences
Nucleus Accumbens Medicine & Life Sciences
Heroin Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Glucose Medicine & Life Sciences
Dopamine Plasma Membrane Transport Proteins Medicine & Life Sciences
Parkinsonian Disorders Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

Action observation with dual task for improving cognitive abilities in parkinson’s disease: A pilot study

Caligiore, D., Mustile, M., Fineschi, A., Romano, L., Piras, F., Assogna, F., Pontieri, F. E., Spalletta, G. & Baldassarre, G., Jan 24 2019, In : Frontiers in Systems Neuroscience. 13, 7.

Research output: Contribution to journalArticle

Open Access
Aptitude
Parkinson Disease
Observation
Short-Term Memory
Therapeutics

Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism

Assogna, F., Pellicano, C., Cravello, L., Savini, C., Macchiusi, L., Pierantozzi, M., Stefani, A., Mercuri, B., Caltagirone, C., Pontieri, F. E. & Spalletta, G., Dec 1 2019, In : Brain and Behavior. 9, 12, e01448.

Research output: Contribution to journalArticle

Open Access
Anhedonia
Progressive Supranuclear Palsy
Affective Symptoms
Parkinsonian Disorders
Parkinson Disease

Drug Choices and Advancements for Managing Depression in Parkinson`s Disease

Assogna, F., Pellicano, C., Savini, C., Macchiusi, L., Pellicano, G. R., Alborghetti, M., Caltagirone, C., Spalletta, G. & Pontieri, F. E., Oct 15 2019, In : Current Neuropharmacology.

Research output: Contribution to journalArticle

Parkinson Disease
Depression
Pharmaceutical Preparations
Antidepressive Agents
Parkinsonian Disorders

Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease

Fanciulli, A., Goebel, G., Lazzeri, G., Scherfler, C., Gizewski, E. R., Granata, R., Kiss, G., Strano, S., Colosimo, C., Pontieri, F. E., Kaufmann, H., Seppi, K., Poewe, W. & Wenning, G. K., Mar 1 2019, In : Movement Disorders. 34, 3, p. 440-441 2 p.

Research output: Contribution to journalLetter

Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson’s disease patients

Hamid, Z., Basit, A., Pontis, S., Piras, F., Assogna, F., Bossù, P., Pontieri, F. E., Stefani, A., Spalletta, G., Franceschi, P., Reggiani, A. & Armirotti, A., May 1 2019, In : Metabolomics. 15, 5, 74.

Research output: Contribution to journalArticle

Open Access
Ethanolamines
Parkinson Disease
Plasmas
Down-Regulation
Phosphatidylethanolamines